期刊文献+

不同剂量西地那非治疗新生儿肺动脉高压合并下肢深静脉血栓的疗效 被引量:8

The Effect of Different Doses of Sildenafil in the Treatment of Lower Extremity deep Venous Thrombosis and Pulmonary Artery Pressure of the Newborn
下载PDF
导出
摘要 目的观察不同剂量西地那非在新生儿肺动脉高压合并患者中的临床效果。方法取2015年3月至2016年10月医院收治新生儿肺动脉高压合并下肢深静脉血栓患者80例,随机数字法分为对照组(n=40)和观察组(n=40)。对照组采用1.0 mg/(kg·d)西地那非治疗,观察组采用2.0 mg/(kg·d)西地那非治疗,比较两组临床疗效。结果两组治疗前肺动脉压及二氧化碳血氧分压水平比较差异无统计学意义(P>0.05);观察组治疗后肺动脉压及二氧化碳血氧分压水平,低于对照组(P<0.05);观察组治疗后药物不良反应发生率为7.50%,对照组为5.00%(P>0.05)。结论新生儿肺动脉高压合并下肢深静脉血栓患儿采用2.0 mg/(kg·d)西地那非治疗效果较为理想。 Objective To observe the clinical effect of different doses of sildenafil in patients with pulmonary hypertension of the newborn. Methods 80 cases of neonatal pulmonary hypertension complicated with lower extremity deep venous thrombosis in our hospital from March 2015 to 2016 were randomly divided into control group ( n = 40) and observation group ( n = 40 ). The control group was treated with 1.0 mg/( kg · D) sildenafil treatment, observation group were treated with 2.0 mg/( kg · D)sildenafil treatment, compared 2 groups of clinical curative effect. Results The 2 groups before treatment, pulmonary artery pressure and partial pressure of carbon dioxide levels had no significant difference ( P 〉 0. 05 ) ; the observation group after treatment, pulmonary artery pressure and partial pressure of carbon dioxide levels lower than the control group ( P 〈 0. 05) ;the patients in the observation group the incidence of adverse reaction was 7.50% and 5% in the control group ( P 〉 0.05 ). Conclusion Neonatal pulmonary hypertension in patients with lower extremity deep venous thrombosis were treated with 2.0mg/( kg · d ) the curative effect of sildenafil, it is worthy of popularization and application.
出处 《血栓与止血学》 2017年第6期964-966,共3页 Chinese Journal of Thrombosis and Hemostasis
关键词 西地那非 肺动脉高压 深静脉血栓 Sildenafil Pulmonary hypertension Deep vein thrombosis
  • 相关文献

参考文献8

二级参考文献72

  • 1柳志红,秦春常.欧洲心脏病学会肺动脉高压指南解读[J].中国实用内科杂志,2007,27(4):243-246. 被引量:23
  • 2Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapyfor pulmonary arterial hypertension. N Engl J Med, 2005, 353: 2148- 2157.
  • 3冯宇,莫绪明.西地那非治疗先天性心脏病伴肺动脉高压的研究进展.中华临床医师杂志,2011,6:426-428.
  • 4Haworth SG, Hislop AA, Treatment and survival in children with pulmonary arterial hytertention: the UK Pulmonary Hypertension Srvice for Children 2001-2006. Heart, 2009, 95:312-317.
  • 5Pfizer Ltd. REVATIO U. S. Physician Prescribing Information2007[ DB/OL]. [ 2009-11 ]. http//media, pfizer, corn/files/products/uspi_ revatio, pdf.
  • 6Teng R J,Wu TJ. Persistent pulmonary hypertension of the newborn[J].Journal of the Formosan Medical Association,2013,(04):177-184.
  • 7Steinhorn RH. Neonatal pulmonary hypertension[J].Pediatric Critical Care Medicine,2010,(Suppl 2):79-84.
  • 8金汉珍;黄德珉;官希吉.实用新生儿学[M]北京:人民卫生出版社,2003421-567.
  • 9Gao Y,Raj JU. Regulation of the pulmonary circulation in the fetus and newborn[J].Physiological Reviews,2010,(04):1291-1335.
  • 10Rocha G,Baptista M J,Guimaraes H. Persistent pulmonary hypertension of non cardiac cause in a neonatal intensive care unit[J].Pulm Med,2012.818971.

共引文献107

同被引文献51

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部